
BMS appoints Dr Veronique Walsh
pharmafile | January 5, 2011 | Appointment | Sales and Marketing | BMS, Bristol-Myers Squibb, Dr Véronique Walsh, appointment, sales and marketing
Bristol-Myers Squibb UK has appointed Dr Véronique Walsh as business unit director, neuroscience and immunoscience .
She joins the company from Sanofi Pasteur MSD UK, where she was deputy managing director in charge of market access, public affairs, communications and strategic planning.
Véronique joined Sanofi Pasteur MSD UK in 1996 and subseqently held a variety of senior roles in the UK and Ireland.
In her new role Véronique will report to recently appointed general manager Amadou Diarra and lead the sales and marketing teams for BMS’ neuroscience and immunoscience portfolio.
Véronique, a French national, is a physician by training who held different hospital and primary care positions in France before joining the pharmaceutical industry in 1990.
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Elekta and BMS partner for digital treatment for melanoma
Elekta and Bristol Myers Squibb have announced a pilot collaboration in which the companies plan …

BMS acquires Mirati Therapeutics for $4.8bn
Bristol Myers Squibb (BMS) and Mirati Therapeutics have announced that they have entered into a …






